FDA Issues New Boxed Warning for Xeljanz, Xeljanz XR

By Nikki Kean

The FDA has approved new boxed warnings about an increased risk of thrombosis and of death associated with the 10-mg twice-daily dose of tofacitinib (Xeljanz, Xeljanz XR, Pfizer), according to a statement from the FDA.